Now showing items 21-30 of 1621
Brief Glutamine Pretreatment Increases Alveolar Macrophage CD163/Heme Oxygenase-1/p38-MAPK Dephosphorylation Pathway and Decreases Capillary Damage but Not Neutrophil Recruitment in IL-1/LPS-Insufflated Rats.
(PLoS One, 2015)
BACKGROUND: Glutamine (GLN) attenuates acute lung injury (ALI) but its effect on alveolar macrophages is unknown. We hypothesized that GLN pretreatment would induce the anti-inflammatory CD163/heme oxygenase (HO)-1/p38-MAPK ...
A few of our favorite unconfirmed ideas.
(Crit Care, 2015)
Medical practice is rooted in our dependence on the best available evidence from incremental scientific experimentation and rigorous clinical trials. Progress toward determining the true worth of ongoing practice or suggested ...
Clinical review: Optimizing enteral nutrition for critically ill patients--a simple data-driven formula.
(Crit Care, 2011)
In modern critical care, the paradigm of 'therapeutic nutrition' is replacing traditional 'supportive nutrition'. Standard enteral formulas meet basic macro- and micronutrient needs; therapeutic enteral formulas meet these ...
Probiotic and synbiotic therapy in critical illness: a systematic review and meta-analysis.
(Crit Care, 2016-08-19)
BACKGROUND: Critical illness is characterized by a loss of commensal flora and an overgrowth of potentially pathogenic bacteria, leading to a high susceptibility to nosocomial infections. Probiotics are living non-pathogenic ...
Refusal in testicular cancer patients: implications for surveillance.
(Br J Cancer, 1992-05)
The imaging viewpoint: how imaging affects determination of progression-free survival.
(Clin Cancer Res, 2013-05-15)
Tumor measurements on computed tomgoraphic or MRI scans and/or the appearance of new lesions on any of a variety of imaging studies including positron emission tomographic scans are key determinants for assessing progression-free ...
Request for regulatory guidance for cancer cachexia intervention trials.
(J Cachexia Sarcopenia Muscle, 2015-12)